M. Langlois

Isolation of the serotoninergic 5‐HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6‐glial and CHO cell lines

F. Lezoualc’h, R. Fischmeister, J. Hoebeke, 2000, British journal of pharmacology.

The 5‐HT4 receptor antagonist ML10375 inhibits the constitutive activity of human 5‐HT4(c) receptor

R. Fischmeister, O. Blondel, M. Gastineau, 1998, British journal of pharmacology.

The immunophenotype of Ewing's sarcoma. An immunohistochemical analysis.

H. Roels, A. Dierick, M. Langlois, 1993, Pathology, research and practice.

The prognostic significance of the DNA content in Ewing's sarcoma: a retrospective cytophotometric and flow cytometric study

P. Oostveldt, H. Roels, A. Dierick, 1993, Histopathology.

Pharmacological characterization of the human 5‐HT4(d) receptor splice variant stably expressed in Chinese hamster ovary cells

F. Lezoualc’h, R. Fischmeister, M. Langlois, 2000, British journal of pharmacology.

Exploration of the ligand binding site of the human 5‐HT4 receptor by site‐directed mutagenesis and molecular modeling

F. Lezoualc’h, R. Fischmeister, J. Hoebeke, 2000, British journal of pharmacology.